- Home
- APLS vs CAAP Comparison
APLS vs CAAP Comparison
Compare APLS & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- CAAP
- Stock Information
- Founded
- APLS 2009
- CAAP 1998
- Country
- APLS United States
- CAAP Luxembourg
- Employees
- APLS N/A
- CAAP N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- CAAP Aerospace
- Sector
- APLS Health Care
- CAAP Consumer Discretionary
- Exchange
- APLS Nasdaq
- CAAP Nasdaq
- Market Cap
- APLS 3.5B
- CAAP 3.4B
- IPO Year
- APLS 2017
- CAAP 2018
- Fundamental
- Price
- APLS $27.97
- CAAP $21.72
- Analyst Decision
- APLS Buy
- CAAP Strong Buy
- Analyst Count
- APLS 20
- CAAP 2
- Target Price
- APLS $34.11
- CAAP $24.35
- AVG Volume (30 Days)
- APLS 3.0M
- CAAP 103.6K
- Earning Date
- APLS 07-31-2025
- CAAP 08-20-2025
- Dividend Yield
- APLS N/A
- CAAP N/A
- EPS Growth
- APLS N/A
- CAAP N/A
- EPS
- APLS N/A
- CAAP 0.93
- Revenue
- APLS $754,649,000.00
- CAAP $1,873,095,000.00
- Revenue This Year
- APLS $10.84
- CAAP $0.91
- Revenue Next Year
- APLS $10.51
- CAAP $12.63
- P/E Ratio
- APLS N/A
- CAAP $23.82
- Revenue Growth
- APLS 20.02
- CAAP 27.19
- 52 Week Low
- APLS $16.10
- CAAP $14.00
- 52 Week High
- APLS $41.94
- CAAP $22.85
- Technical
- Relative Strength Index (RSI)
- APLS 74.59
- CAAP 58.93
- Support Level
- APLS $26.23
- CAAP $20.46
- Resistance Level
- APLS $28.87
- CAAP $22.85
- Average True Range (ATR)
- APLS 1.07
- CAAP 0.72
- MACD
- APLS 0.18
- CAAP 0.07
- Stochastic Oscillator
- APLS 84.04
- CAAP 61.61
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.